Current Investments
Sort: All | Life Sciences | Information Technologies | Cleantech
| AEGEA Medical Medical device technology for the in-office treatment of excessive menstrual bleeding |
||
 |
AnaptysBio Antibody therapeutics company and emerging leading in antibody discovery and optimization. |
|
 |
Cameron Health Minimally invasive implantable leadless defibrillator |
|
 |
CoAlign Innovations Spinal implants for treatment of lower back pain |
|
 |
Crux Biomedical |
|
 |
Fluidigm Integrated fluidic circuits. (NYSE: FLDM) |
|
 |
ForteBio Analytical systems for characterization of biomolecular interactions |
|
 |
KaloBios Technology for improving antibody drugs |
|
 |
KFx Medical Device for percutaneous repair systems for rotator cuff repair |
|
 |
Labcyte Inc. Developer of ultrasound-based and other instruments for drug discovery and development. |
|
 |
Novasys Medical Catheter for treating female urinary stress incontinence |
|
 |
NuGEN Technologies Tools for genetic analysis |
|
 |
Optimedica Laser based opthamology instruments |
|
 |
Pacific Biosciences Ultra-fast DNA sequencing. (NYSE: PACB) |
|
 |
RainDance Technologies |
|
 |
Restoration Robotics Robotic tools for cosmetic surgery |
|
 |
SynergEyes Contact lenses delivering high visual acuity and comfort |
|
 |
Verinata Health Non-invasive prenatal screening & diagnostic tests |
|
“Mike Hunkapiller has been a tremendous asset as a Director. He has contributed to our market development strategies, our recruiting efforts, financing, and even our technology development plans. There are few like him in the health care industry.”
– Gajus Worthington, CEO of Fluidigm
